- We will break even in Central Eastern Europe next year: Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals
Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals Ltd., in a chat to ET Now, talks about the company's performance and its future pla...
- Glenmark Pharmaceuticals to initiate filing for Crofelemer as Salix submits NDA
Glenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.
- Napo termination will not impact company: Glenmark
In an interview with ET Now, Glenn Saldanha, Chairman and Managing Director, Glenmark, gives his views on the company's strategies. Excerpt...